INFORMED: an incubator at the US FDA for driving innovations in data science and agile technology

10.1038/nrd.2018.34

2018-04-06

INFORMED: an incubator at the US FDA for driving innovations in data science and agile technology INFORMED: an incubator at the US FDA for driving innovations in data science and agile technology, Published online: 06 April 2018; doi:10.1038/nrd.2018.34Inform...

The gastroesophageal cancer drug market

10.1038/nrd.2018.35

2018-04-03

The gastroesophageal cancer drug market The gastroesophageal cancer drug market, Published online: 03 April 2018; doi:10.1038/nrd.2018.35Immune checkpoint inhibitors are forecast to expand the market for gastroesophageal cancer drugs, which is particularly la...

Antivirals: Topical therapy for ocular herpes

10.1038/nrd.2018.47

2018-03-28

Antivirals: Topical therapy for ocular herpes Antivirals: Topical therapy for ocular herpes, Published online: 28 March 2018; doi:10.1038/nrd.2018.47Antivirals: Topical therapy for ocular herpes

Infectious disease: Virus-based tuberculosis vaccine

10.1038/nrd.2018.50

2018-03-28

Infectious disease: Virus-based tuberculosis vaccine Infectious disease: Virus-based tuberculosis vaccine, Published online: 28 March 2018; doi:10.1038/nrd.2018.50Infectious disease: Virus-based tuberculosis vaccine

Immunotherapy: iPSC-based cancer vaccine

10.1038/nrd.2018.48

2018-03-28

Immunotherapy: iPSC-based cancer vaccine Immunotherapy: iPSC-based cancer vaccine, Published online: 28 March 2018; doi:10.1038/nrd.2018.48Immunotherapy: iPSC-based cancer vaccine

George Yancopoulos

10.1038/nrd.2018.41

2018-03-28

George Yancopoulos George Yancopoulos, Published online: 28 March 2018; doi:10.1038/nrd.2018.41George Yancopoulos, CSO of Regeneron, discusses his 30 years at Regeneron, the company's evolving growth plans and the recent launch of a precompetitive collaborati...

Neurodevelopmental disorders: CRISPR to the rescue

10.1038/nrd.2018.39

2018-03-28

Neurodevelopmental disorders: CRISPR to the rescue Neurodevelopmental disorders: CRISPR to the rescue, Published online: 28 March 2018; doi:10.1038/nrd.2018.39Neurodevelopmental disorders: CRISPR to the rescue

Market watch: Upcoming market catalysts in Q2 2018

10.1038/nrd.2018.43

2018-03-28

Market watch: Upcoming market catalysts in Q2 2018 Market watch: Upcoming market catalysts in Q2 2018, Published online: 28 March 2018; doi:10.1038/nrd.2018.43Market watch: Upcoming market catalysts in Q2 2018

Sepsis: Gut bacteria induce protective IgA

10.1038/nrd.2018.49

2018-03-28

Sepsis: Gut bacteria induce protective IgA Sepsis: Gut bacteria induce protective IgA, Published online: 28 March 2018; doi:10.1038/nrd.2018.49Sepsis: Gut bacteria induce protective IgA

Drug delivery: DNA nanorobots — seek and destroy

10.1038/nrd.2018.40

2018-03-28

Drug delivery: DNA nanorobots — seek and destroy Drug delivery: DNA nanorobots — seek and destroy, Published online: 28 March 2018; doi:10.1038/nrd.2018.40Drug delivery: DNA nanorobots — seek and destroy